Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,809 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07106827 | A Study of GV20-0251 in Advanced or Refractory Solid Tumors | recruiting | Phase 1 | 10 | West China HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07242014 | 68Ga-XACP3 PET/CT in Prostate Cancer | recruiting | N/A | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05236686 |
| Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer |
| recruiting |
| N/A |
| 94 |
| Shanghai Gynecologic Oncology GroupOTHER_GOV |
| 1 |
| Nov 19, 2025 |
| clinicaltrials |
| NCT06482983 | The Effects of VC Versus PC Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery | recruiting | N/A | 120 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Nov 19, 2025 | clinicaltrials |
| NCT03408964 | Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients | recruiting | — | 600 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT03954171 | Platino-resistance in Ovarian Cancer(PlatinOv) | recruiting | N/A | 600 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT04543799 | Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer(SIESTA) | recruiting | — | 60 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05773859 | NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer(NEODOC) | recruiting | Phase 1 / Phase 2 | 10 | Radboud University Medical CenterOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05850182 | Lifestyle Intervention in Patients With Metastatic Prostate Cancer(ACTIDIET-PRO) | recruiting | N/A | 30 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05984875 | The Immune Landscape of Epithelial Ovarian Cancer(IOSI-GYNE-001) | recruiting | — | 74 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06588322 | Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy(ATROVA) | recruiting | N/A | 130 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06917781 | Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome(TAYLOR) | recruiting | N/A | 80 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06935305 | OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer(SENT-OSNA) | recruiting | N/A | 1,922 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07131956 | Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | recruiting | — | 200 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07163910 | Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study | recruiting | Phase 2 | 93 | baotai LiangOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06398067 | Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam | recruiting | N/A | 285 | Boston UniversityOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT07231159 | Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots | recruiting | — | 200 | AdventHealthOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT04473833 | Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer | recruiting | N/A | 65,000 | John R van NagellOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT04115254 | Stereotactic Magnetic Resonance Guided Radiation Therapy | recruiting | N/A | 397 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT05997017 | Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer | recruiting | Phase 2 | 29 | Aadi Bioscience, Inc.INDUSTRY | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06677112 | MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer | recruiting | N/A | 625 | Rachel MillerOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT07084168 | Multimedia Aid for Genetic Testing in Gynecologic Oncology | recruiting | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06398639 | Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer(PRS) | recruiting | N/A | 1,500 | Adam S. Kibel, MDOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT04550845 | Understanding of Genetics by Men at Risk for Prostate Cancer | recruiting | N/A | 90 | Mayo ClinicOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT07071207 | Effect of Text Message Reminders on M-ISI Score After Prostate Surgery(TextMsgM-ISI) | recruiting | N/A | 132 | University of RochesterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT06062745 | Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT | recruiting | Phase 1 | 30 | Brigham and Women's HospitalOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06659614 | Prostate Tissue BioBank(PTBB) | recruiting | — | 200 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | recruiting | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT07044505 | Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery | recruiting | N/A | 50 | Stanford UniversityOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT05902988 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | recruiting | Phase 1 / Phase 2 | 200 | Volastra Therapeutics, Inc.INDUSTRY | 1 | Nov 4, 2025 | clinicaltrials |
| NCT06481592 | A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. | recruiting | Phase 2 | 60 | Iovance Biotherapeutics, Inc.INDUSTRY | 1 | Oct 30, 2025 | clinicaltrials |
| NCT07219303 | Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer(DE-CART) | recruiting | N/A | 80 | Fox Chase Cancer CenterOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT07222436 | Circulating Tumor DNA in High Risk Localized Prostate Cancer | recruiting | — | 24 | University of PittsburghOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT06617923 | Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer | recruiting | Phase 2 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT05919329 | Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy | recruiting | Phase 4 | 80 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT05512208 | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib(DURAFAK) | recruiting | Phase 2 | 55 | University of OklahomaOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT06165302 | Exercise in Prostate Cancer | recruiting | N/A | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04586959 | Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer(MAN-U) | recruiting | N/A | 278 | Anthony Costales, MDOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT06141993 | ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials(ARCTIC) | recruiting | — | 120 | Duke UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT06817161 | Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:(ESTANVO) | recruiting | Phase 3 | 116 | Centre Francois BaclesseOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT06960291 | Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada(EXCEL) | recruiting | N/A | 740 | University of CalgaryOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07141121 | Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen(IMARHGIN) | recruiting | N/A | 78 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07209878 | 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI | recruiting | Phase 2 / Phase 3 | 100 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT05869682 | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy | recruiting | Phase 2 | 210 | City of Hope Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT06433349 | A Multi-center Investigation of Family Health. | recruiting | — | 240 | Odense University HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT04644289 | WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC(WoO) | recruiting | Phase 2 | 60 | AGO Research GmbHINDUSTRY | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05603559 | 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer | recruiting | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT06517901 | Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer(FOCUS-PC) | recruiting | N/A | 1,306 | Albany Medical CollegeOTHER | 2 | Oct 3, 2025 | clinicaltrials |
| NCT07166042 | Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies(Med-RT BG) | recruiting | Phase 3 | 34 | University of UtahOTHER | 1 | Oct 3, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Nov 24, 2025source: clinicaltrials